The Commission’s Medication Safety Program is advised by a number of standing committees and other advisory groups related to specific projects or initiatives. Ensuring appropriate representation is critical to the applicability and utility of program resources developed for health professionals, consumers and organisations. In addition, and in relation to specific initiatives, the Commission will consult more broadly by inviting comments from specific groups or generally.
Medication Reference Group
The Medication Reference Group provides high-level, strategic advice to the Commission on medication matters. It first met in July 2009 and is chaired by Professor Lloyd Sansom AO. It includes health professional, consumer, academic, policy, research, regulatory, private and public sector representatives.
- Medication Reference Group membership (Word 41 KB)
- Medication Reference Group terms of reference (PDF 61 KB)
- Medication Reference Group meeting 6 outcomes 24 March 2011 (Word 49 KB)
- Medication Reference Group meeting 7 outcomes 21 July 2011 (word 41 KB)
- Medication Reference Group meeting 8 outcomes 28 November 2011 (Work 48 KB)
- Medication Reference Group meeting 9 outcomes 15 March 2012 (Word 38 KB)
If you require earlier meeting outcomes, contact the Commission at mail@safetyandquality.gov.au.
Health Service Medication Expert Advisory Group
The Health Service Medication Expert Advisory Group advises the Commission on the NIMC, other national standardisations and related issues. It includes public and private hospital, health professional, professional organisation, paediatric and policy representatives. It is a sub-committee of the Medication Reference Group.
Medication Continuity Expert Advisory Group
The Medication Continuity Expert Advisory Group advises the Commission on improving the quality of medication information transferred in and across care settings. It also advises the Commission on its role as Lead Technical Agency as part of Australia’s involvement in the World Health Organization’s High 5 Patient Safety Initiative. It includes public and private sector, consumer, academic, health professional, professional organisation and policy representatives. It is a sub-committee of the Medication Reference Group.
- Medication Continuity Expert Advisory Group membership (Word 38 KB)
- Medication Continuity Expert Advisory Group terms of reference (PDF 67 KB)
- Medication Continuity Expert Advisory Group meeting 5 outcomes 25 January 2011 (Word 35 KB)
- Medication Continuity Expert Advisory Group meeting 6 outcomes 16 March 2011 (Word 32 KB)
- Medication Continuity Expert Advisory Group meeting 7 outcomes 8 June 2011 (Word 32 KB)
- Medication Continuity Expert Advisory Group meeting 8 outcomes 14 September 2011 (Word 33 KB)
- Medication Continuity Expert Advisory Group meeting 9 outcomes 15 February 2012 (Word 33 KB)
If you require earlier meeting outcomes, contact the Commission at mail@safetyandquality.gov.au.
Anticoagulation Working Group
The Anticoagulation Working Group advises the Commission on NIMC modifications required to improve the safe and appropriate use of venous thrombo-prophylaxis and on national requirements for a specialist anticoagulation chart. The group is a sub-committee of the Health Services Medication Expert Advisory Group. It includes public and private sector, academic, health professional, and policy representatives. It is a sub-committee of the Medication Reference Group.
- Anticoagulation Working Group membership (Word 35 KB)
- Anticoagulation Working Group terms of reference (PDF 50 KB)
- Anticoagulation Working Group meeting 2 outcomes 18 February 2010 (Word 73 KB)
- Anticoagulation Working Group meeting 3 outcomes 13 May 2011 (Word 97 KB)
- Anticoagulation Working Group meeting 4 outcomes 7 September 2011 (Word 84 KB)
- Anticoagulation Working Group meeting 5 outcomes 16 January 2012 (Word 153 KB)
- Anticoagulation Working Group meeting 6 outcomes 19 June 2012 (Word 99 KB)
National Residential Medication Chart Reference Group
The National Residential Medication Chart Reference Group advises the Commission on its Commonwealth-funded project to develop a nationally standard medication chart for use in residential aged care facilities. It includes public and private sector, consumer, academic, health professional, industry organisations and policy representatives.
The National Residential Medication Chart is expected to be available for aged care services in the latter half of 2013.
National Insulin Form Pilot Advisory Group
The National Insulin Form Pilot Advisory Group advises the Commission on national piloting of the draft National Subcutaneous Insulin Form. It includes public and private sector, academic, health professional, professional organisation and policy representatives. It is a sub-committee of the Medication Reference Group.
- National Insulin Form Pilot Advisory Group membership (Word 31 KB)
- National Insulin Form Pilot Advisory Group terms of reference (PDF 69 KB)
- National Insulin Form Pilot Advisory Group meeting 1 outcomes 28 August 2012 (Word 98 KB)
Antimicrobial Stewardship Committee
The Antimicrobial Stewardship Advisory Committee advises the Commission on effective antimicrobial stewardship program strategies and on conduct of the Antimicrobial Stewardship Program. It includes public and private sector, academic, health professional and policy representatives.
Labelling Recommendations Reference Group
The Labelling Recommendations Reference Group advises the Commission on maintenance of the National Recommendations for User-applied Labelling of Injectable Medicines, Fluids and Lines. It includes public and private sector, academic, health professional, industry organisations and policy representatives. It is a sub-commitee of the Health Services Medication Expert Advisory Group.
Outcomes of the group’s deliberations are reflected in the Labelling Recommendations Issues Register and in the Labelling Recommendations Frequently Asked Questions.